STACEY BROCK: Open Payments
NPI 1285370296 · FAIRFIELD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,079 in 43 payments from 25 companies in 2025. Trend: 2023 $165 · 2024 $758 · 2025 $1,079
Food & beverage: $980Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $177 |
| Ipsen Biopharmaceuticals, Inc | 1 | $99 |
| Merck Sharp & Dohme LLC | 3 | $83 |
| AstraZeneca Pharmaceuticals LP | 3 | $79 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $50 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Stemline Therapeutics Inc. | 2 | $37 |
| Janssen Biotech, Inc. | 2 | $36 |
Products named: IMBRUVICA, KEYTRUDA, Nubeqa, SCEMBLIX, OPDIVO, Orserdu, EPKINLY, LIBTAYO.
Industry payments across OH — which companies pay providers there.
